Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CorVel Corporation's SEC filings document the company's public-company reporting for a technology-enabled risk management business serving workers' compensation and health, auto, and liability programs. Recent 8-K filings furnish quarterly financial results through Item 2.02 disclosures and related earnings press releases.
CorVel's proxy and annual meeting filings cover stockholder voting matters, director elections, auditor ratification, and governance procedures. The filings also identify the company's common stock, par value $0.0001 per share, traded under CRVL on the Nasdaq Global Select Market, tying its governance record to its listed equity security.
CRVL submitted a Form 144 notice for the proposed sale of 28,500 shares of Common Stock. The filing lists a transaction method tied to previously exercised options dated 02/11/2022 and shows an aggregate value of $1,706,152.50 with an entry date of 06/08/2026.
The filing also records that Michael G. Combs sold 8,013 shares on 03/09/2026 for $432,702.00. The notice includes a reference figure of 50,691,185 (listed in the excerpt) on 06/08/2026.
CorVel Corporation announced a planned leadership transition effective July 1, 2026. Longtime executive Sarah Scott will become Chief Executive Officer and President, succeeding Michael G. Combs, who will move to the new role of Executive Chair on the same date.
Scott has been with CorVel for more than 26 years and most recently served as Executive Vice President, Product and Corporate Services. Her compensation as CEO and President will include a $600,000 annual base salary, a performance-based cash bonus opportunity, and a grant of 25,000 stock options under the 2025 Stock Incentive Plan.
Combs, who has led the company as President since 2017 and CEO since 2019, will focus on advising Scott, maintaining key relationships, and supporting long-term strategic planning as Executive Chair, for which he will receive $25,000 per month and continued health benefits.
CorVel Corp Vice President of Accounting Jennifer Yoss exercised stock options and sold the resulting shares of common stock. On May 26, 2026, she exercised options for a total of 1,999 shares at strike prices of $49.63 and $51.997 per share, then sold 1,999 shares in open-market transactions at an average price of $61.0205 per share.
According to the filing’s transaction summary, the net effect was a decrease of 1,999 shares in her position. Following these transactions, Yoss directly owns 2,173 shares of CorVel common stock. No remaining stock options are shown in this filing.
CorVel Corporation is a Delaware-based provider of medical cost containment and managed care services focused on workers’ compensation, auto, liability and group health claims. The company combines nationwide PPO and directed care networks with AI-driven bill review, claims management and case management delivered via its CareMC platform.
As of September 30, 2025, non‑affiliate equity had an aggregate market value of $2.22 billion, based on 28.7 million shares. During fiscal 2026, CorVel repurchased 782,744 shares for $56.2 million, bringing cumulative buybacks to 115.3 million shares at a cost of about $888 million, with 1.74 million shares still authorized. The company employed 5,239 people as of March 31, 2026 and highlights extensive use of artificial intelligence, machine learning and cybersecurity programs as both growth drivers and key risk areas.
CorVel Corporation reported solid growth for the quarter and fiscal year ended March 31, 2026. Fiscal year revenues rose to $958.5 million, up from $895.6 million, while diluted earnings per share increased to $2.14 from $1.83, a 17% gain. Quarterly revenues reached $248.5 million versus $231.5 million a year earlier, and diluted EPS grew to $0.61 from $0.51, a 20% increase.
Fourth-quarter gross profit was $63.0 million at a 25% margin, and net income for the quarter was $31.0 million. The company ended the period with $233.1 million in cash and cash equivalents and no borrowings, and it repurchased $20.1 million of common stock during the quarter. Management highlighted strong demand in its CERIS health division and ongoing technology and AI investments across payment accuracy, workers’ compensation, and risk management services.
CorVel Corp Chief Financial Officer Brian S. Nichols exercised stock options and settled related tax obligations using shares. On May 1, 2026, he exercised a non-qualified stock option for 18 shares of common stock at $39.827 per share. In connection with this exercise, a total of 13 shares of common stock, valued at $57.53 per share, were delivered to cover the option exercise price and associated tax liability, as reflected in two tax-withholding dispositions. The remaining shares from the option exercise increased his directly held common stock position by a small amount. The filing notes that employee stock plan participation changes since the prior report are not included here.
CorVel Corp executive Mark E. Bertels reported routine equity compensation activity. On April 22, 2026, he exercised a non-qualified stock option to acquire 1,050 shares of CorVel common stock at an exercise price of $39.827 per share.
To cover the option exercise price and related tax liabilities, 830 shares of common stock were delivered back, in two transactions coded "F" at prices of $57.40 and $56.76 per share, as described in the footnotes. These tax-withholding dispositions are not open-market sales and reflect standard handling of equity compensation rather than discretionary buying or selling.
CORVEL CORP Vice President of Accounting Jennifer Yoss acquired 50 shares of common stock through an Employee Stock Purchase Plan transaction exempt under SEC Rule 16b-3(c). The shares were acquired at a price of $51.9175 per share. Following this award, she directly holds 2,173 shares of CORVEL common stock.
CORVEL CORP CEO Michael G. Combs acquired 62 shares of common stock on an award basis at $51.9175 per share. The shares were obtained under the company’s Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c). Following this grant, he directly holds 40,822 shares.